NCT02534233Completed
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium
Source: ClinicalTrials.gov · Last updated 1 Aug 2025
Brief summary (registry, in English)
Assess Cryoablation (CryoBalloon Ablation cryotherapy) for treatment of Dysplastic Barrett's Esophagus, Esophageal Squamous Dysplasia and early Esophageal Cancer. The cryoablation treatment will be offered as an alternative to standard ablation therapies such as Radiofrequency Ablation, Argon Plasma Coagulation and carbon dioxide Cryotherapy).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 19 Aug 2015
- Start date
- 1 Apr 2015
- Primary completion date
- 31 Aug 2024
- Lead sponsor
- Johns Hopkins University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT02534233
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 1 Apr 2015 to the primary completion date, 31 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient unable to undergo endoscopy,
- Patients with visible esophageal mass.
Who the study is looking for
- Patients recommended for ablation of either Barrett's esophagus with dysplasia or esophageal squamous dysplasia, scheduled for upper endoscopy.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins Hospital Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.